Leishmania-HIV interaction: Immunopathogenic mechanisms

Parasitology Today

Volumn 15, Issue 5, 1999, Pages 182-187

  Wolday, D ^a   Berhe, N ^b   Akuffo, H ^c   Britton, S ^a  

^a ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LEISHMANIA; LYMPHOCYTE FUNCTION; MICROBIAL GROWTH; NONHUMAN; OPPORTUNISTIC INFECTION; REVIEW; SUPERINFECTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; PROTOZOA; RNA VIRUSES;

EID: 0033135736     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(99)01431-3     Document Type: Review

References (73)

1. 1 Fauci, A.S. et al. (1991) Immunopathogenic mechanisms in HIV infection. Ann. Intern. Med. 114, 678-693
2. 2 Gilks, C.F. (1993) The clinical challenge of the HIV epidemic in the developing world. Lancet 342, 1037-1039
3. 3 Galai, N. et al. (1997) African HIV-1 subtype C and the rate of progression among Ethiopian immigrants to Israel. Lancet 349, 180-181
4. 4 Abebe, A. et al. HIV subtype-C from Ethiopian AIDS patients are preferentially non-syncytium inducing variants. AIDS (in press)
5. 5 Kristiansen, T.B., Knudsen, T.B. and Eugen-Olsen, J. (1998) Chemokine receptors and their crucial role in HIV infection: major breakthroughs in HIV research. Scand. J. Immunol. 48, 339-346
6. 6 Gartner, S. et al. (1986) The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233, 215-219
7. 7 Stevenson, M. et al. (1990) HIV replication is controlled at the level of T-cell activation and proviral integration. EMBO J. 9, 1151-1160
8. 8 Mellors, J.W. et al. (1996) Prognosis in HIV infection predicted by the quantity of virus in plasma. Science 272, 1267-1270
9. 9 Wilson, M.E. et al. (1992) in Molecular Recognition in Host-Parasite Interactions (Korkonen, T.K., Hovi, T. and Makela, P.H., eds), pp 17-30, Plenieum Publishing
10. 10 Murray, H.W. et al. (1983) Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon gamma is the activating cytokine. J. Clin. Invest. 72, 1506-1510
11. 11 Desjeux, P. (1996) Leishmaniasis: public aspects and control. Clin. Dermatol. 14, 417-423
12. 12 World Health Organization (1997) The current global situation of HIV/AIDS pandemic. Weekly Epidemiol. Rec. 72, 357-360
13. 13 World Health Organization (1997) Leishmania-HIV co-infection. Epidemiological analysis of 692 retrospective cases. Weekly Epidemiol. Rec. 72, 49-54
14. 14 Alvar, J. et al. (1996) AIDS and Leishmania infantum: new approaches for a new epidemiological problem. Clin. Dermatol. 14, 241-246
15. 15 Desjeux, P. and UNAIDS (1998) Leishmania and HIV in Gridlock. WHO/CTD/LEISH/98.9 Add. I, UNAIDS/98.23. World Health Organization, Geneva, Switzerland
16. 16 Berhe, N. et al. (1995) Ethiopian visceral leishmaniasis patients co-infected with HIV-1. Trans. R. Soc. Trop. Med. Hyg. 89, 205-207
17. 17 Berhe, N., Hailu, A. and Gemetchu, T. (1995) HIV and recurrence of cutaneous leishmaniasis long after healed localized cutaneous leishmaniasis due to Leishmania aethiopica. Trans. R. Soc. Trop. Med. Hyg. 89, 400-401
18. 18 Pharoah, P.D. et al. (1993) Two cases of cutaneous leishmaniasis in Malawi. Trans. R. Soc. Trop. Med. Hyg. 87, 668-670
19. 19 Alvar, J. et al. (1997) Leishmania and HIV co-infection: the first 10 years. Clin. Microbiol. Rev. 10, 298-319
20. 20 Reed, S.G. et al. (1992) Cytokine activation of human macro-phages infected with HIV-1 to inhibit intracellular protozoa. J. AIDS 5, 666-675
21. 21 Wolday, D. et al. (1994) HIV-1 inhibits Leishmania-induced cell proliferation, but not TNF-α and IL-6 production. Scand. J. Immunol. 39, 380-386
22. 22 Pisa, P. et al. (1990) Serum TNF levels and disease dissemination in leprosy and leishmaniasis. J. Infect. Dis. 161, 988-991
23. 23 Cenini, P. et al. (1993) Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J. Infect. Dis. 168, 986-993
24. 24 Poli, G. and Fauci, A.S. (1995) in Human Cytokines: Their Role in Health and Human Disease (Aggarwal, B.B. and Puri, R.K., eds), pp 421-449, Blackwell
25. 25 Bernier, R. et al. (1995) Activation of HIV-1 in monocytoid cells by the protozoan parasite L. donovani. J. Virol. 69, 7282-7285
26. 26 Wolday, D. et al. (1998) Live and killed HIV-1 increases the intracellular growth of L. donovani in monocyte-derived cells. Scand. J. Infect. Dis. 30, 29-34
27. 27 Martinez, P. et al. (1993) Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS 7, 227-230
28. 28 Hsia, K. et al. (1995) Low prevalence of HIV-1 proviral DNA in peripheral blood monocytes and dendritic cells from HIV-1-infected individuals. AIDS 9, 398-399
29. 29 Wahl, S.M. et al. (1989) HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J. Immunol. 142, 3553-3559
30. Ba-L: effect on accessory cell function for T-cell proliferation in vitro. AIDS Res. Hum. Retroviruses 7, 465-473
31. 31 Petit, A.J.C. et al. (1989) HIV down regulates HLA class II expression and induces differentiation in promonocytic U937 cells. J. Clin. Invest. 79, 1883-1889
32. 32 Baldwin, G.C. et al. (1990) HIV causes mononuclear phagocyte dysfunction. Proc. Natl. Acad. Sci. U. S. A. 87, 3933-3937
33. 33 Tas, M. et al. (1988) A monocyte chemotaxis inhibiting factor in serum of HIV infected men shares epitopes with the HIV trans-membrane protein gp41. Clin. Exp. Immunol. 71, 13-18
34. 34 Murray, H.W. et al. (1989) In vitro and in vivo activation of human mononuclear phagocytes by interferon-γ. Studies with normal and AIDS monocytes. J. Immunol. 138, 2457-2462
35. 35 Embretson, J. et al. (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 359-362
36. 36 Bentwich, Z. et al. (1995) Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol. Today 16, 187-191
37. 37 Bentwich, Z. et al. (1996) Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminthic infections. Clin. Exp. Immunol. 103, 239-243
38. 38 Schinittmann, S.M. et al. (1989) The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245, 305-308
39. 39 Ho, D.D. et al. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126
40. 40 Bernier, R. et al. (1998) The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-κB elements. J. Immunol. 160, 2881-2888
41. 41 Easterbrook, M.D. et al. (1995) Inhibition of HIV-1 induced syncytia formation and infectivity by lipophosphoglycan from Leishmania. J. AIDS Hum. Retrovirol. 10, 496-505
42. 42 Xiao, L. et al. (1998) Plasmodium falciparum antigen-induced HIV-1 replication is mediated through induction of TNF-α. J. Infect. Dis. 177, 437-445
43. 43 Bleul, C.C. et al. (1997) The HIV coreceptors CXCR4 and CCR5 are differently expressed and regulated on human T-lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 94, 1925-1930
44. 44 Shapira-Nahor, O. et al. (1998). Increased susceptibility to HIV-1 of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS 12, 1731-1733
45. 45 Bentwich, Z. et al. (1997). Pathogenesis of AIDS in Africa: lessons from the Ethiopian immigrants in Israel. Immunologist 5, 21-26
46. 46 Muro-Cacho, C.A. et al (1995) Analysis of apoptosis in lymph nodes of HIV-infected persons: intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154, 5555-5566
47. 47 Mosmann, T.R. and Coffman, R.L. (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional property. Annu. Rev. Immunol. 7, 145-173
48. + subsets in leishmaniasis. J. Cell. Biochem. 53, 323-328
49. 49 Clerici, M. and Shearer, G.M. (1994) The Th1-Th2 hypothesis of HIV-1 infection: new insights. Immunol. Today 15, 575-581
50. 50 Clerici, M. et al. (1994) Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with HIV. J. Clin. Invest. 93, 768-775
51. 51 Maggi, E. et al. (1994) Ability of HIV-1 to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265, 244-248
52. 52 Graziosi, C. et al. (1994) Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265, 248-252
53. 53 Sarih, M., Maataoui, W.E. and Benslimane, A. (1996) Analysis of apoptosis and Th1/Th2 phenotype in HIV-infected patients. Immunol. Lett. 50, 125-129
54. 54 Hu, R. et al. (1994) HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon gamma and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro. Clin. Immunol. Immunopathol. 73, 245-251
55. 55 Cacopardo, B. et al. (1996) Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans. R. Soc. Trop. Med. Hyg. 90, 434-435
56. 56 Aebischer, T. (1994) Recurrent cutaneous leishmaniasis: a role for persistent parasite? Parasitol. Today 10, 25-28
57. 57 Badaro, R. et al. (1986) New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 154, 1003-1011
58. 58 Meller-Melloul, C. et al. (1991) Evidence of subjects sensitized to Leishmania infantum on the French Mediterannean coast: differences in gamma-interferon production between this population and visceral leishmaniasis patients. Parasite Immunol. 13, 531-536
59. 59 Carvalho, E.M. et al. (1992) Immunological markers of clinical evolution in children recently infected with Leishmania chagasi donovani. J. Infect. Dis. 165, 535-540
60. 60 Kurtzhals, J.A.L. et al. (1992) Cellular and humoral immune re-activity of a population in Baringo District, Kenya, to Leishmania promastigote lipophosphoglycan. Am. J. Trop. Med. Hyg. 46, 480-488
61. 61 Sacks, D.L. et al. (1987) An analysis of T-cell responsiveness in Indian Kala-azar. J. Immunol. 138, 908-913
62. 62 Carvalho, E.M. et al. (1985) Absence of gamma-interferon and interleukin-2 production during active visceral leishmaniasis. J. Clin. Invest. 76, 2066-2069
63. 63 Karp, C.L. et al. (1993) In vivo cytokine profiles in patients with Kala-azar; marked elevation of both interleukin-10 and interferon-gamma. J. Clin. Invest. 91, 1644-1648
64. 64 Ghalib, H.G. et al. (1993) Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92, 324-329
65. 65 Carvalho, E.M. et al. (1994) Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152, 5949-5956
66. 66 Cenini, P. et al. (1994) Mononuclear cell subpopulations in HIV-positive versus HIV-negative patients with visceral leishmaniasis. J. Infect. Dis. 169, 707-708
67. + T cells suppress HIV replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. U. S. A. 92, 2308-2313
68. + T-lymphocytes with HIV-1. Lancet 348, 649-654
69. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc. Natl. Acad. Sci. U. S. A. 90, 948-952
70. 70 Badaro, R. and Johnson, W.D. (1993) The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis. J. Infect. Dis. 167 (Suppl. 1), S13-S17
71. 71 de-Gorgolas, M., Castrillo, J.M. and Fernandez-Guerrero, M.L. (1993) Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma. Clin. Infect. Dis. 17, 56-58
72. 72 Albrecht, H. et al. (1994) Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient. Clin. Invest. 72, 1041-1047
73. 73 Tramontana, J.M. et al. (1995) Thalidomide treatment reduces TNF-α production and enhances weight gain in patients with pulmonary tuberculosis. Mol. Med. 1, 384-397